Why measure liver fat?

Steatotic Liver Disease (SLD), excess fat in the liver, affects billions globally. Early detection and management of SLD is critical in improving metabolic health and outcomes.

SLD is often asymptomatic and not easily detectable at the early stages. As the number of people with SLD continues to rise, its strong link to metabolic syndrome and a range of chronic conditions such as obesity, type 2 diabetes, cardiovascular disease, and even liver cancer is becoming more evident. Thus, detecting and managing these conditions as soon as possible is key.


Healthy liver		Non-Alcoholic Fatty Liver Disease (NAFLD)		Non-Alcoholic Steatohepatitis (NASH)		Fibrosis		Cirrhosis or cancer

Until now, options for detection have been limited.

Current diagnostic methods remain inadequate, as there is no reliable, inexpensive, point-of-care test available, meaning detection and monitoring of liver fat for most patients is out of the question.

ENDRA’s technology allows for early detection of steatotic liver disease (SLD) (excessive fat in the liver).

TAEUS® is a new, proprietary way to measure fat in the liver that is noninvasive and accessible – a “blood pressure cuff” for liver fat measurement. The technology is now CE-marked for sale in Europe.

Learn more about TAEUS® >

Get TAEUS® >

TAEUS® is CE-marked for sale in Europe. Not yet FDA approved for sale in the US. CAUTION – INVESTIGATIONAL DEVICE. Limited by Federal (or United States) law to investigational use.

TAEUS® uses a unique, groundbreaking combination of radio frequency and ultrasound to characterize human tissue in a way similar to MRI – at the point of patient care.

TAEUS® establishes key biomarkers for metabolic disease detection and management.

Get TAEUS® >

Endra Explained

“If we could diagnose MASLD-MASH early in the disease cycle, while it is still reversible, with a tool that is safe and easily accessible at the point of patient care, it could improve the health of millions of people and dramatically lower healthcare costs associated with later-stage acute disease management. ENDRA’s TAEUS® liver device could be a game changer in the clinical care cycle of liver disease.”

— Sam Gambhir, M.D, Ph.D

Former Chair, Dept. of Radiology and Director, Molecular Imaging Program, Stanford University, In Memoriam (1962–2020)

What is TAEUS®?

Technology that will revolutionize what doctors can see and do at the patient bedside.

WATCH THE VIDEO >

Meet Mary

Learn how ENDRA is using ultrasound to help make difficult-to-diagnose diseases easier to find and treat.

WATCH THE VIDEO >

TAEUS® for clinicians

See how TAEUS® is making it easier and more cost-effective than ever to assess and monitor fat in the liver.

WATCH THE VIDEO >

See more. Do more. Live better.™

GET IN TOUCH WITH ENDRA >